Prevention and Treatment of Amatoxin Induced Hepatic Failure With Intravenous Silibinin ( Legalon SIL): An Open Multicenter Clinical Trial
Phase of Trial: Phase II/III
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Silibinin (Primary)
- Indications Poisoning
- Focus Therapeutic Use
- Sponsors Madaus
- 03 Apr 2017 Planned End Date changed from 1 Dec 2016 to 31 Dec 2018.
- 03 Apr 2017 Planned primary completion date changed from 1 Sep 2016 to 31 Dec 2018.
- 18 Mar 2016 According to ClinicalTrials.gov record,Primary end point has been revised .